About 20 years ago, the snake antivenin CroFab entered the market and dramatically reduced the adverse reactions associated with treatment, Dr. Steven Curry says. But the drug came with a sky-high price tag. In one case reported by NPR and Kaiser Health News, an Indiana hospital last summer charged nearly $68,000 for four vials of CroFab.